Miniaturized scintillator dosimeter for small field radiation therapy

The concept of a miniaturized inorganic scintillator detector is demonstrated in the analysis of the small static photon fields used in external radiation therapy. Such a detector is constituted by a 0.25 mm diameter and 0.48 mm long inorganic scintillating cell (1.6 × 10^-5cm³detection volume) efficiently coupled to a narrow 125μm diameter silica optical fiber using a tiny photonic interface (an optical antenna). The response of our miniaturized scintillator detector (MSD) under 6 MV bremsstrahlung beam of various sizes (from 1 × 1 cm²to 4 × 4 cm²) is compared to that of two high resolution reference probes, namely, a micro-diamond detector and a dedicated silicon diode. The spurious Cerenkov signal transmitted through our bare detector is rejected with a basic spectral filtering. The MSD shows a linear response regarding the dose, a repeatability within 0.1% and a radial directional dependence of 0.36% (standard deviations). Beam profiling at 5 cm depth with the MSD and the micro-diamond detector shows a mismatch in the measurement of the full widths at 80% and 50% of the maximum which does not exceed 0.25 mm. The same difference range is found between the micro-diamond detector and a silicon diode. The deviation of the percentage depth dose between the MSD and micro-diamond detector remains below 2.3% within the first fifteen centimeters of the decay region for field sizes of 1 × 1 cm², 2 × 2 cm²and 3 × 3 cm²(0.76% between the silicon diode and the micro-diamond in the same field range). The 2D dose mapping of a 0.6 × 0.6 cm²photon field evidences the strong 3D character of the radiation-matter interaction in small photon field regime. From a beam-probe convolution theory, we predict that our probe overestimates the beam width by 0.06%, making our detector a right compromise between high resolution, compactness, flexibility and ease of use. The MSD overcomes problem of volume averaging, stem effects, and despite its water non-equivalence it is expected to minimize electron fluence perturbation due to its extreme compactness. Such a detector thus has the potential to become a valuable dose verification tool in small field radiation therapy, and by extension in Brachytherapy, FLASH-radiotherapy and microbeam radiation therapy.

Six-probe scintillator dosimeter for treatment verification in HDR-brachytherapy

BACKGROUND

In vivo dosimetry (IVD) is gaining interest for treatment delivery verification in HDR-brachytherapy. Time resolved methods, including source tracking, have the ability both to detect treatment errors in real time and to minimize experimental uncertainties. Multiprobe IVD architectures holds promise for simultaneous dose determinations at the targeted tumor and surrounding healthy tissues while enhancing measurement accuracy. However, most of the multiprobe dosimeters developed so far either suffer from compactness issues or rely on complex data post-treatment.

PURPOSE

We introduce a novel concept of a compact multiprobe scintillator detector and demonstrate its applicability in HDR-brachytherapy. Our fabricated seven-fiber probing system is sufficiently narrow to be inserted in a brachytherapy needle or in a catheter.

METHODS

Our multiprobe detection system results from the parallel implementation of six miniaturized inorganic Gd2 O2 S:Tb scintillator detectors at the end of a bundle of seven fibers, one fiber is kept bare to assess the stem effect. The resulting system, which is narrower than 320 microns, is tested with a MicroSelectron 9.14 Ci Ir-192 HDR afterloader, in a water phantom. The detection signals from all six probes are simultaneously read with a sCMOS camera (at a rate of 0.06 s). The camera is coupled to a chromatic filter to cancel Cerenkov signal induced within the fibers upon exposure. By implementing an aperiodic array of six scintillating cells along the bundle axis, we first determine the range of inter-probe spacings leading to optimal source tracking accuracy (first tracking method). Then, three different source tracking algorithms involving all the scintillating probes are tested and compared. In each of these four methods, dwell positions are assessed from dose measurements and compared to the treatment plan. Dwell time is also determined and compared to the treatment plan.

RESULTS

The optimum inter-probe spacing for an accurate source tracking ranges from 15 to 35 mm. The optimum detection algorithm consists of adding the readout signals from all detector probes. In that case, the error to the planned dwell positions is of 0.01 ± 0.14 mm and 0.02 ± 0.29 mm at spacings between the source and detector axes of 5.5 and 40 mm, respectively. Using this approach, the average deviations to the expected dwell time are of- 0.006 ± 0.009 $-0.006\,\pm \,0.009$ s and- 0.008 ± 0.058 $-0.008\, \pm 0.058$ s, at spacings between source and probe axes of 5.5 and 20 mm, respectively.

CONCLUSIONS

Our six-probe Gd2 O2 S:Tb dosimeter coupled to a sCMOS camera can perform time-resolved treatment verification in HDR brachytherapy. This detection system of high spatial and temporal resolutions (0.25 mm and 0.06 s, respectively) provides a precise information on the treatment delivery via a dwell time and position verification of unmatched accuracy.

Characterization of a miniaturized scintillator detector for time-resolved treatment monitoring in HDR-brachytherapy

Purpose.HDR brachytherapy combines steep dose gradients in space and time, thereby requiring detectors of high spatial and temporal resolution to perform accurate treatment monitoring. We demonstrate a miniaturized fiber-integrated scintillator detector (MSD) of unmatched compactness which fulfills these conditions.Methods.The MSD consists of a 0.28 mm large and 0.43 mm long detection cell (Gd₂O₂S:Tb) coupled to a 110 micron outer diameter silica optical fiber. The fiber probe is tested in a phantom using a MicroSelectron 9.1 Ci Ir-192 HDR afterloader. The detection signal is acquired at a rate of 0.08 s with a standard sCMOS camera coupled to a chromatic filter (to cancel spurious Cerenkov signal). The dwell position and time monitoring are analyzed over prostate treatment sequences with dwell times spanning from 0.1 to 11 s. The dose rate at the probe position is both evaluated from a direct measurement and by reconstruction from the measured dwell position using the AAPM TG-43 formalism.Results.A total number of 1384 dwell positions are analyzed. In average, the measured dwell positions differ by 0.023 ± 0.077 mm from planned values over a 6-54 mm source-probe distance range. The standard deviation of the measured dwell positions is below 0.8 mm. 94% of the 966 dwell positions occurring at a source-probe inter-catheter spacing below 20 mm are successfully identified, with a 100% detection rate for dwell times exceeding 0.5 s. The average deviation to the planned dwell times is of 0.005 ± 0.060 s. The instant dose retrieval from dwell position monitoring leads to a relative mismatch to planned values of 0.14% ± 0.7%.Conclusion.A miniaturized Gd2O₂S:Tb detector coupled to a standard sCMOS camera can be used for time-resolved treatment monitoring in HDR Brachytherapy.